Boer Daniel Anton de, Chief Executive Officer at ProQR Therapeutics, bought PRQR on Jul 9, 2026
Data as of Oct 16
▲ BUY$261K150,000 shares at $1.74Boer Daniel Anton de Chief Executive OfficerPRQR ProQR Therapeutics N.V.
- Traded
- Jul 9, 2026
- Disclosed
- Jul 13, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PRQR since disclosure
−22.9%
Similar stocks (XLV) since disclosure
+9.5%
XLV — its sector index fund
Change in closing price from Jul 13, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.